We’ve talked a lot about how drugs are developed, why they cost as much as they do while they’re patented, and how we can make them more accessible to all. Through it all, we hope to have shown that drugs, as opposed to other areas of healthcare, are a great deal for society and far from the rip-off that some would have us believe. We’d like to leave you with one (and a half) more articles that underscore that point and bring together a lot of the concepts we’ve discussed:
In “A Lot for a Little: The Best 8% of Our Healthcare Dollar,](https://rapport.bio/all-stories/best-8-percent-of-our-healthcare-dollar)\” Peter Kolchinsky highlights how branded prescription drugs account for a small portion of healthcare spending in the U.S. This modest investment drives medical innovation, leading to new treatments that eventually become affordable generics. This cycle not only enhances patient care but also results in long-term cost savings, emphasizing that drugs are indeed a great deal for society.
And don’t forget the “But What About](https://rapport.bio/supplementals/but-what-about)” epilogue, an FAQ about the drug industry that addresses many of the criticisms we often hear.